Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease

被引:0
作者
Yang, X. -P. [1 ]
Wang, M. [1 ]
Li, T. -F. [1 ]
Li, W. [1 ]
Zhang, L. [1 ]
Liu, S. -Y. [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Rheumatol, E Jianshe Rd 1, Zhengzhou 450052, Henan, Peoples R China
关键词
adult-onset Still's disease; ferritin; splenomegaly; pericarditis; macrophage activation syndrome; DIAGNOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To summarise the clinical data of adult-onset Still's disease (AOSD) patients and analyse their clinical manifestations, predictors for the formation and prognosis of macrophage activation syndrome (MAS). Methods. A retrospective analysis was performed on the clinical data of 182 AOSD hospitalised patients from the Department of Rheumatology of the First Affiliated Hospital of Zhengzhou University, China from January 2012 to August 2018, including 11 patients with pathogenesis of MAS. Results. Compared with the patients without MAS, the patients with MAS had a higher incidence of splenomegaly and pericarditis at the initial diagnosis of AOSD. The number of platelets (PLT) and the concentration of fibrinogen (FIB), D-Dimer and ferritin were significantly higher in AOSD-MAS patients. Multivariate regression analysis showed that splenomegaly (OR: 5.748, 95% CI: 1.378-23.984, p=0.016), pericarditis (OR: 6.492, 95% CI: 1.43-29.461, p=0.015), and ferritin >2000 mu g/L (OR: 4.715, 95% CI: 1.12-19.86, p=0.035) were risk factors for MAS. Survival analysis indicated that the mortality of AOSD-MAS patients was significantly higher than patients without MAS. Conclusion. Splenomegaly, pericarditis and elevated ferritin concentration are risk factors for MAS formation in AOSD patients. MAS resulted in a significant decrease in the survival rate of the AOSD patients.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 27 条
[1]   Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease [J].
Assari, Raheleh ;
Ziaee, Vahid ;
Mirmohammadsadeghi, Arash ;
Moradinejad, Mohammad-Hassan .
DISEASE MARKERS, 2015, 2015 :1-8
[2]   Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease Clinical Features, Predictive Factors, and Prognosis in 21 Patients [J].
Bae, Chang-Bum ;
Jung, Ju-Yang ;
Kim, Hyoun-Ah ;
Suh, Chang-Hee .
MEDICINE, 2015, 94 (04)
[3]   Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment [J].
Carter, Stuart J. ;
Tattersall, Rachel S. ;
Ramanan, Athimalaipet V. .
RHEUMATOLOGY, 2019, 58 (01) :5-17
[4]   A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? [J].
Dall'Ara, Francesca ;
Frassi, Micol ;
Tincani, Angela ;
Airo, Paolo .
CLINICAL RHEUMATOLOGY, 2016, 35 (08) :2117-2123
[5]   Life-threatening complications of adult-onset Still's disease [J].
Efthimiou, Petros ;
Kadavath, Sabeeda ;
Mehta, Bella .
CLINICAL RHEUMATOLOGY, 2014, 33 (03) :305-314
[6]   Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome [J].
Fardet, Laurence ;
Galicier, Lionel ;
Lambotte, Olivier ;
Marzac, Christophe ;
Aumont, Cedric ;
Chahwan, Doumit ;
Coppo, Paul ;
Hejblum, Gilles .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) :2613-2620
[7]   Mechanisms, biomarkers and targets for adult-onset Still's disease [J].
Feist, Eugen ;
Mitrovic, Stephane ;
Fautrel, Bruno .
NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (10) :603-618
[8]  
GABAY C FB, 2018, ANN RHEUM DIS, V77, P1
[9]   Adult-onset Still's disease [J].
Gerfaud-Valentin, Mathieu ;
Jamilloux, Yvan ;
Iwaz, Jean ;
Seve, Pascal .
AUTOIMMUNITY REVIEWS, 2014, 13 (07) :708-722
[10]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131